Zhiling Yan

Epithelial–mesenchymal transition: a new target in anticancer drug discovery

Advances and challenges in targeting FGFR signalling in cancer

Cellular senescence in ageing: from mechanisms to therapeutic opportunities

Pemigatinib for previously treated, locally advanced or metastatic cholangiocarcinoma: a multicentre, open-label, phase 2 study

Caspase inhibitors: a review of recently patented compounds (2013-2015)

Epithelial Mesenchymal Transition in Tumor Metastasis

Emerging Cytotoxic Alkaloids in the Battle against Cancer: Overview of Molecular Mechanisms

Intratumoral activation of the necroptotic pathway components RIPK1 and RIPK3 potentiates antitumor immunity

EMT, CSCs, and drug resistance: the mechanistic link and clinical implications

Discovery of piperlongumine as a potential novel lead for the development of senolytic agents

Plant Secondary Metabolites as Anticancer Agents: Successes in Clinical Trials and Therapeutic Application

Blockage of caspase-1 activation ameliorates bone marrow inflammation in mice after hematopoietic stem cell transplantation

Piperlongumine selectively suppresses ABC-DLBCL through inhibition of NF-κB p65 subunit nuclear import

TGF-β1 and FGF2 Stimulate the Epithelial-Mesenchymal Transition of HERS Cells Through a MEK-Dependent Mechanism